Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer

被引：0
|
作者：
Aung, Wint Yan
Lee, Chung-Shien
Morales, Jaclyn
Kohn, Nina
Rahman, Husneara
Seetharamu, Nagashree
机构：
[1] Northwell Hlth, Manhasset, NY USA
[2] Northwell Hlth Canc Inst, New Hyde Pk, NY USA
[3] Feinstein Inst Med Res, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of anlotinib in combination with immune checkpoint inhibitors or not as advanced non-small cell lung cancer treatment: a systematic review and network meta-analysis
    Wu, Zhengyu
    Zhou, Peng
    Zhao, Yanan
    Wang, Junping
    Gao, Shan
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (05) : 2451 - 2463
  • [22] Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Dar, Sophia
    Merza, Nooraldin
    Rahim, Mehek
    Qatani, Ahmad
    Varughese, Tony
    Mohammad, Asna
    Masood, Fahad
    Reza, Fizza
    Wan, Schuchen
    Almas, Talal
    Ellahi, Aayat
    Ligresti, Rosario
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [23] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [24] Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis
    Tan, Kexin
    Wang, Aolin
    Zheng, Yumin
    Wang, Shuo
    Wang, Chao
    Li, Jia
    Lu, Xingyu
    Dong, Huijing
    Zheng, Jiabin
    Cui, Huijuan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (01): : 196 - 203
  • [25] The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis
    Dai, Linzheng
    Jin, Bo
    Liu, Tingting
    Chen, Jun
    Li, Guang
    Dang, Jun
    ECLINICALMEDICINE, 2021, 38
  • [26] Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis
    Chen, Ching-Yi
    Huang, Chi-Hsien
    Chen, Wang-Chun
    Huang, Ming-Shyan
    Wei, Yu-Feng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [27] Sarcopenia as a Determinant of the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Meta-Analysis
    Ren, Bixin
    Shen, Jiucheng
    Qian, Yajuan
    Zhou, Tong
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 685 - 695
  • [28] Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis
    Giustozzi, Michela
    Becattini, Cecilia
    Roila, Fausto
    Agnelli, Giancarlo
    Mandala, Mario
    CANCER TREATMENT REVIEWS, 2021, 100
  • [29] Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
    Guaitoli, Giorgia
    Tiseo, Marcello
    Di Maio, Massimo
    Friboulet, Luc
    Facchinetti, Francesco
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2890 - 2916
  • [30] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Hong, Shaodong
    Tan, Min
    Wang, Shouzheng
    Luo, Shengyuan
    Chen, Yue
    Zhang, Li
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 909 - 921
12345